Table 1.
Pathways/processes impacted by curcumin and analogues, and their effect on viruses.
Pathway/Process | Antiviral Activity | Virus | References |
---|---|---|---|
Actin filament organization | Viral entry | Dengue virus Viral hemorrhagic septicemia virus |
[8] [9] |
Replication | Dengue virus | [8] | |
Anti-inflammation | Replication | Human immunodeficiency virus | [10] |
Antioxidation | Replication | Human immunodeficiency virus | [11] |
APE1 redox reactions | Replication | Kaposi’s sarcoma-associated herpesvirus | [12] |
Cell lipogenesis | Replication | Dengue virus | [8] |
Cleavage of eIF4G | Protein expression | Enterovirus 71 | [13] |
Conformation of viral/cellular surface proteins | Viral attachment | Zika virus Chikungunya virus Vesicular stomatitis virus |
[14,15,16] |
Human respiratory syncytial virus | [17,18] | ||
HSC71 expression | Viral entry | Viral hemorrhagic septicemia virus | [9] |
NF-κB signalling | Replication | Influenza A virus | [19] |
Viral egress | Herpes simplex virus 2 | [10] | |
PKCδ phosphorylation | Protein expression? | Enterovirus 71 | [20] |
ROS production | Viricidal | Norovirus | [21,22] |
Lipid raft formation | Bovine herpes virus 1 | [23] | |
Viral enzymes | Viral egress Viral protease |
Influenza A virus Dengue virus |
[24] [8] |
Viral proteins | Viral entry | Influenza A virus Porcine reproductive and respiratory syndrome virus |
[24] [25] |
Viral protein degradation | Human immunodeficiency virus | [26] | |
Viricidal | Norovirus | [21] |